| Acquired by | WuXi PharmaTech (Cayman) |
| Price | $203M |
| Date | 1/08 |
| Website | apptecls.com |
| Category | BioTech |
| Phone | 651-675-2000 |
| Employees | |
| Founded | 1982 |
| TOTAL | $11M |
| VENTURE FUNDING TOTAL | $11M |
| Venture Round, 2/05 NewSpring Capital Commerce Health Capital | $11M |
WuXi AppTec, Inc. provides GLP/GMP compliant discovery, testing, and contract manufacturing services for pharmaceuticals, biopharmaceuticals, cellular therapeutics, medical devices, and tissue-based products. The company offers biopharmaceuticals/cellular therapeutics services, including cell banking, protein therapeutics manufacturing services, various testing services; and toxicology services, such as biodistribution and expression analysis, biocompatibility/safety testing, histology and pathology, in-life, in-life/toxicology services, and orthopedic implant studies. It also provides testing services for various medical devices, and tissue-based products/combination products. In addition, the company offers analytical development, analytical supporting, bioanalytical, discovery biology, discovery chemistry DMPK and ADMET, pharmaceutical development, process chemistry and scale up, and research manufacturing services. WuXi AppTec, Inc. was formerly known as AppTec Laboratory Services, Inc. The company was founded in 1982 and is based in Saint Paul, Minnesota. As of January 31, 2008, WuXi AppTec, Inc. operates as a subsidiary of WuXi PharmaTech (Cayman) Inc.
